Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived?
Saved in:
Main Author: | Dimitrios Patoulias |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2019-09-01
|
Series: | Gastroenterology Review |
Online Access: | https://www.termedia.pl/Liraglutide-for-non-alcoholic-fatty-liver-disease-in-children-and-adolescents-has-a-new-era-arrived-,41,37806,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes,
and cardiovascular disease
by: Dimitrios Patoulias, et al.
Published: (2018-12-01) -
Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
by: Yuan-Yuan Xu, et al.
Published: (2024-09-01) -
New aspects of non-alcoholic fatty liver disease
by: V. V. Tsukanov, et al.
Published: (2015-09-01) -
Profile of Children With Non-alcoholic Fatty Liver Disease Referred to a Hospital in Iran
by: Amin Ghanbari, et al.
Published: (2024-12-01) -
Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)